Clinical Trial Update: Impact of Infliximab in Fistulizing Crohn's Disease on Health Care Resources (Study P04204)(TERMINATED)

View source ↗

Summary

This terminated clinical trial (P04204) evaluated the impact of infliximab for fistulizing Crohn's disease on health care resource use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Crohn Disease | Status: TERMINATED